These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 33826022)

  • 81. High Awareness, Yet Low Uptake, of Pre-Exposure Prophylaxis Among Adolescent Girls and Young Women Within Family Planning Clinics in Kenya.
    Sila J; Larsen AM; Kinuthia J; Owiti G; Abuna F; Kohler PK; John-Stewart G; Pintye J
    AIDS Patient Care STDS; 2020 Aug; 34(8):336-343. PubMed ID: 32757980
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review.
    Pleuhs B; Quinn KG; Walsh JL; Petroll AE; John SA
    AIDS Patient Care STDS; 2020 Mar; 34(3):111-123. PubMed ID: 32109141
    [TBL] [Abstract][Full Text] [Related]  

  • 83. HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda.
    Koss CA; Havlir DV; Ayieko J; Kwarisiima D; Kabami J; Chamie G; Atukunda M; Mwinike Y; Mwangwa F; Owaraganise A; Peng J; Olilo W; Snyman K; Awuonda B; Clark TD; Black D; Nugent J; Brown LB; Marquez C; Okochi H; Zhang K; Camlin CS; Jain V; Gandhi M; Cohen CR; Bukusi EA; Charlebois ED; Petersen ML; Kamya MR; Balzer LB
    PLoS Med; 2021 Feb; 18(2):e1003492. PubMed ID: 33561143
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries.
    Pretorius C; Schnure M; Dent J; Glaubius R; Mahiane G; Hamilton M; Reidy M; Matse S; Njeuhmeli E; Castor D; Kripke K
    J Int AIDS Soc; 2020 Feb; 23(2):e25451. PubMed ID: 32112512
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Evaluation of an HIV Pre-Exposure Prophylaxis Referral System: From Sexual Health Center to Federally Qualified Health Center Pre-Exposure Prophylaxis Clinic.
    Lillis R; Beckford J; Fegley J; Siren J; Hinton B; Gomez S; Taylor SN; Butler I; Halperin J; Clement ME
    AIDS Patient Care STDS; 2021 Sep; 35(9):354-359. PubMed ID: 34448603
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A Clinical Home for Preexposure Prophylaxis: Diverse Health Care Providers' Perspectives on the "Purview Paradox".
    Hoffman S; Guidry JA; Collier KL; Mantell JE; Boccher-Lattimore D; Kaighobadi F; Sandfort TG
    J Int Assoc Provid AIDS Care; 2016; 15(1):59-65. PubMed ID: 26293904
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Examination of HIV Preexposure Prophylaxis Need, Availability, and Potential Pharmacy Integration in the Southeastern US.
    Harrington KRV; Chandra C; Alohan DI; Cruz D; Young HN; Siegler AJ; Crawford ND
    JAMA Netw Open; 2023 Jul; 6(7):e2326028. PubMed ID: 37498599
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings.
    Marcus JL; Volk JE; Pinder J; Liu AY; Bacon O; Hare CB; Cohen SE
    Curr HIV/AIDS Rep; 2016 Apr; 13(2):116-24. PubMed ID: 26898645
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations - Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine.
    Rousseau E; Julies RF; Madubela N; Kassim S
    Curr HIV/AIDS Rep; 2021 Dec; 18(6):500-507. PubMed ID: 34708316
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Uptake and Acceptability of Oral HIV Self-Testing among Community Pharmacy Clients in Kenya: A Feasibility Study.
    Mugo PM; Micheni M; Shangala J; Hussein MH; Graham SM; Rinke de Wit TF; Sanders EJ
    PLoS One; 2017; 12(1):e0170868. PubMed ID: 28125699
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The Impact of HIV Pre-Exposure Prophylaxis (PrEP) Counseling on PrEP Knowledge and Attitudes Among Women Seeking Family Planning Care.
    O'Connell HR; Criniti SM
    J Womens Health (Larchmt); 2021 Jan; 30(1):121-130. PubMed ID: 32493156
    [No Abstract]   [Full Text] [Related]  

  • 92. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.
    Biello KB; Bazzi AR; Mimiaga MJ; Biancarelli DL; Edeza A; Salhaney P; Childs E; Drainoni ML
    Harm Reduct J; 2018 Nov; 15(1):55. PubMed ID: 30419926
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Oral PrEP Consultations Among Adolescent Girls and Young Women in Kisumu County, Kenya: Insights from the DREAMS Program.
    Heck CJ; Mathur S; Alwang'a H; Daniel OM; Obanda R; Owiti M; Okal J
    AIDS Behav; 2022 Aug; 26(8):2516-2530. PubMed ID: 35099640
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Considering Stigma in the Provision of HIV Pre-Exposure Prophylaxis: Reflections from Current Prescribers.
    Calabrese SK; Tekeste M; Mayer KH; Magnus M; Krakower DS; Kershaw TS; Eldahan AI; Gaston Hawkins LA; Underhill K; Hansen NB; Betancourt JR; Dovidio JF
    AIDS Patient Care STDS; 2019 Feb; 33(2):79-88. PubMed ID: 30715918
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Client Perspectives on the Development of a Rapid PrEP Initiative at a Sexual Health Center in New Orleans, Louisiana.
    Lovett A; Luder R; Lillis RA; Butler I; Siren J; Gomez S; Kamis K; Obafemi O; Rowan SE; Baral S; Clement ME
    J Int Assoc Provid AIDS Care; 2024; 23():23259582241258559. PubMed ID: 38839254
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Identification of Determinants and Implementation Strategies to Increase PrEP Uptake Among Black Same Gender-Loving Men in Mecklenburg County, North Carolina: The PrEP-MECK Study.
    Corneli A; Perry B; Wilson J; Reif S; Gulden C; Hanlen-Rosado E; Cooper H; Taylor J; Starling S; Thompson JW
    J Acquir Immune Defic Syndr; 2022 Jul; 90(S1):S149-S160. PubMed ID: 35703767
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Adaptation and psychometric evaluation of a scale to measure oral pre-exposure prophylaxis-related stigma among key and vulnerable populations in Kenya.
    Atkins K; Kan L; Musau A; Reed J; Were D; Mohan D
    J Int AIDS Soc; 2022 Jul; 25 Suppl 1(Suppl 1):e25929. PubMed ID: 35818870
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Barriers and facilitators to pre-exposure prophylaxis uptake among male sex workers in Mexico: an application of the RE-AIM framework.
    Kadiamada-Ibarra H; Hawley NL; Sosa-Rubí SG; Wilson-Barthes M; Franco RR; Galárraga O
    BMC Public Health; 2021 Nov; 21(1):2174. PubMed ID: 34837988
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Preexposure Prophylaxis Implementation in a Reproductive Health Setting: Perspectives From Planned Parenthood Providers and Leaders.
    Wilbourn B; Ogburn DF; Safon CB; Galvao RW; Kershaw TS; Willie TC; Taggart T; Caldwell A; Kaplan C; Phillips N; Calabrese SK
    Health Promot Pract; 2023 Jul; 24(4):764-775. PubMed ID: 35414273
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Implementation of a community pharmacy-based pre-exposure prophylaxis service: a novel model for pre-exposure prophylaxis care.
    Tung EL; Thomas A; Eichner A; Shalit P
    Sex Health; 2018 Nov; 15(6):556-561. PubMed ID: 30401342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.